
|Articles|October 18, 2007
First integrase inhibitor Isentress gets regulatory green light
Raltegravir (Isentress, Merck) receives FDA approval for HIV treatment.
Advertisement
Accelerated approval for Merck's raltegravir (
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
2
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
3
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
4
Zepbound Lowers Health Care Costs in Older Adults With Obesity
5







































